Company / Revenue
Day One Biopharmaceuticals, Inc. Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$158.2M
FY2025
5-year range
$0 / $158.2M
FY2022-FY2025
Trend
+20.6%
vs FY2024
Sector context
#97 of 153
Health Care
What the data says
At $158M, Day One Biopharmaceuticals, Inc.'s revenue ranks #97 of 153 in the Health Care sector. Improved from $0 to $158M over the past 2 years.
Based on SEC 10-K filings.
$158M in FY2025.
Improved from $0 to $158M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 153 in Health CareTop 63% of 153This company $158.2M Sector average $4.5B
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 20.6% year-over-year.
- Ranks #97 out of 153 companies in the Health Care sector.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $158.2M | +20.6% |
| FY2024 | $131.2M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026